Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells

Molecular regulation of synaptogenesis during associative learning and memory

(2015) Thomas J. Nelson et al.   BRAIN RESEARCH

MicroRNAs: Small molecules with big roles in neurodevelopment and diseases

(2015) Emily Sun et al.   EXPERIMENTAL NEUROLOGY

The Mood Stabilizer Lithium Potentiates the Antidepressant-Like Effects and Ameliorates Oxidative Stress Induced by Acute Ketamine in a Mouse Model of Stress

(2015) Chi-Tso Chiu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder

(2015) S Bavamian et al.   MOLECULAR PSYCHIATRY

Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD

(2015) A. Serafin et al.   NEUROLOGY

miR-34: from bench to bedside

(2015) Massimiliano Agostini et al.   Oncotarget

Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders

(2014) O. V. Forlenza et al.   ACS Chemical Neuroscience

Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases

(2014) Li Gan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The Toxic Effect of Lithium Ion on Neurons (PC12 cells) and Aβ42 Molecules

(2014) Wang Yang et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons

(2014) Sung Woo Park et al.   BIPOLAR DISORDERS

The panorama of miRNA-mediated mechanisms in mammalian cells

(2014) Anna Stroynowska-Czerwinska et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

New insights into antioxidant strategies against paraquat toxicity

(2014) T. Blanco-Ayala et al.   FREE RADICAL RESEARCH

Thioredoxin System Regulation in the Central Nervous System: Experimental Models and Clinical Evidence

(2014) Daniela Silva-Adaya et al.   Oxidative Medicine and Cellular Longevity

Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity

(2014) Madhusudhanan Narasimhan et al.   TOXICOLOGY LETTERS

Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach

(2014) Maria Teresa Baltazar et al.   TOXICOLOGY LETTERS

Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy

(2014) Annamaria Vallelunga et al.   Frontiers in Cellular Neuroscience

Dietary Regulation of Keap1/Nrf2/ARE Pathway: Focus on Plant-Derived Compounds and Trace Minerals

(2014) Amanda Stefanson et al.   Nutrients

Environmental Toxins and Parkinson's Disease

(2013) Samuel M. Goldman   Annual Review of Pharmacology and Toxicology

Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders

(2013) Anu Kauppinen et al.   CELLULAR SIGNALLING

Potential Mechanisms of Action of Lithium in Bipolar Disorder

(2013) Gin S. Malhi et al.   CNS DRUGS

Regulation of Nrf2—an update

(2013) Suryakant K. Niture et al.   FREE RADICAL BIOLOGY AND MEDICINE

The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease

(2013) Li Zuo et al.   GENE

Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

(2013) Fabio Blandini   Journal of Neuroimmune Pharmacology

The emerging roles of microRNAs in CNS injuries

(2013) Oneil G. Bhalala et al.   Nature Reviews Neurology

SOD1 and DJ-1 Converge at Nrf2 Pathway: A Clue for Antioxidant Therapeutic Potential in Neurodegeneration

(2013) Pamela Milani et al.   Oxidative Medicine and Cellular Longevity

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

(2013) Shelley J. Allen et al.   PHARMACOLOGY & THERAPEUTICS

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

(2013) Sudhakar Raja Subramaniam et al.   PROGRESS IN NEUROBIOLOGY

Autophagy and apoptosis dysfunction in neurodegenerative disorders

(2013) Saeid Ghavami et al.   PROGRESS IN NEUROBIOLOGY

Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders

(2013) Breno Diniz et al.   Neuropsychiatric Disease and Treatment

Interpreting Magnetic Resonance Imaging Findings in Bipolar Disorder

(2012) David A. Cousins et al.   CNS Neuroscience & Therapeutics

Classic and New Animal Models of Parkinson's Disease

(2012) Javier Blesa et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

MicroRNAs and their roles in aging

(2012) T. Smith-Vikos et al.   JOURNAL OF CELL SCIENCE

Ensembl 2013

(2012) Paul Flicek et al.   NUCLEIC ACIDS RESEARCH

Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells

(2012) Ning Song et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The role of pesticide exposure in the genesis of Parkinson's disease: Epidemiological studies and experimental data

(2012) Angelo Moretto et al.   TOXICOLOGY

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

(2011) Elena Miñones-Moyano et al.   HUMAN MOLECULAR GENETICS

HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs

(2011) J. Robert Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

miR-335 and miR-34a Promote Renal Senescence by Suppressing Mitochondrial Antioxidative Enzymes

(2011) X.-Y. Bai et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice

(2011) Darcy Litteljohn et al.   NEUROSCIENCE LETTERS

Experimental strategies for microRNA target identification

(2011) D. W. Thomson et al.   NUCLEIC ACIDS RESEARCH

Intracellular pathways underlying the effects of lithium

(2010) Livia Pasquali et al.   BEHAVIOURAL PHARMACOLOGY

Paraquat and Parkinson's disease

(2010) C Berry et al.   CELL DEATH AND DIFFERENTIATION

miRTarBase: a database curates experimentally validated microRNA–target interactions

(2010) Sheng-Da Hsu et al.   NUCLEIC ACIDS RESEARCH

Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells

(2010) Wonsuk Yang et al.   TOXICOLOGY LETTERS

The Role of NADPH Oxidase 1–Derived Reactive Oxygen Species in Paraquat-Mediated Dopaminergic Cell Death

(2009) Ana Clara Cristóvão et al.   ANTIOXIDANTS & REDOX SIGNALING

miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation

(2009) Xiaoying Wang et al.   BRAIN RESEARCH BULLETIN

MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment

(2009) Haiming Chen et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

(2009) Pei-Chun Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Paraquat-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells: Involvement of p53 and Mitochondria

(2008) Wonsuk Yang et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

Long-term Exposure to Low Lithium Concentrations Stimulates Proliferation, Modifies Stress Protein Expression Pattern and Enhances Resistance to Oxidative Stress in SH-SY5Y Cells

(2008) M. S. Allagui et al.   NEUROCHEMICAL RESEARCH

Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers

(2008) Rulun Zhou et al.   NEUROPSYCHOPHARMACOLOGY